Truist Financial
ARKG icon

Truist Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Truist Financial’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,210
Closed -$267K – 2796
2025
Q4 		$267K Sell
9,210
-1,761
-16% -$52.9K ﹤0.01% 2408
2025
Q3 		$305K Buy
+10,971
New +$277K ﹤0.01% 2302
2024
Q3 		– Sell
-19,069
Closed -$448K – 2518
2024
Q2 		$448K Sell
19,069
-127
-0.7% -$3.21K ﹤0.01% 2033
2024
Q1 		$552K Sell
19,196
-1,411
-7% -$42.4K ﹤0.01% 1909
2023
Q4 		$676K Sell
20,607
-313
-1% -$8.51K ﹤0.01% 1809
2023
Q3 		$583K Buy
20,920
+889
+4% +$29.1K ﹤0.01% 1841
2023
Q2 		$683K Buy
20,031
+1,266
+7% +$39.8K ﹤0.01% 1788
2023
Q1 		$564K Buy
18,765
+2,763
+17% +$85.6K ﹤0.01% 1905
2022
Q4 		$452K Buy
16,002
+559
+4% +$17.7K ﹤0.01% 2030
2022
Q3 		$507K Sell
15,443
-2,639
-15% -$96.9K ﹤0.01% 1811
2022
Q2 		$569K Sell
18,082
-36,683
-67% -$1.28M ﹤0.01% 1835
2022
Q1 		$2.52M Sell
54,765
-13,888
-20% -$662K ﹤0.01% 1198
2021
Q4 		$4.2M Sell
68,653
-7,715
-10% -$533K 0.01% 953
2021
Q3 		$5.71M Sell
76,368
-47,408
-38% -$3.98M 0.01% 828
2021
Q2 		$11.4M Buy
123,776
+9,789
+9% +$832K 0.02% 586
2021
Q1 		$10.1M Buy
113,987
+77,683
+214% +$7.71M 0.02% 590
2020
Q4 		$3.39M Buy
36,304
+29,250
+415% +$2.33M 0.01% 968
2020
Q3 		$449K Buy
7,054
+2,195
+45% +$129K ﹤0.01% 1780
2020
Q2 		$253K Buy
+4,859
New +$208K ﹤0.01% 2065

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial's ARKG Position: Q1 2026 in Review

Truist Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 9,210 shares — an estimated $267K sold.

Truist Financial first reported a position in ARKG in Q2 2020 and held it in 19 quarters. The position peaked at $11.4M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Truist Financial reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Truist Financial sold 9,210 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $267K.
  • Truist Financial first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 19 quarters.
  • Truist Financial's ARK Genomic Revolution ETF position peaked at $11.4M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.